• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 21, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Aptamers: lifesavers; ion shields: aptamer guardians

Bioengineer by Bioengineer
January 2, 2024
in Biology
Reading Time: 3 mins read
0
Figure 1
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Aptamers, nucleic acids capable of selectively binding to viruses, proteins, ions, small molecules, and various other targets, are garnering attention in drug development as potential antibody substitutes for their thermal and chemical stability as well as ability to inhibit specific enzymes or target proteins through three-dimensional binding. They also hold promise for swift diagnoses of colon cancer and other challenging diseases by targeting elusive biomarkers. Despite their utility, these aptamers are susceptible to easy degradation by multiple enzymes, presenting a significant challenge.

Figure 1

Credit: POSTECH

Aptamers, nucleic acids capable of selectively binding to viruses, proteins, ions, small molecules, and various other targets, are garnering attention in drug development as potential antibody substitutes for their thermal and chemical stability as well as ability to inhibit specific enzymes or target proteins through three-dimensional binding. They also hold promise for swift diagnoses of colon cancer and other challenging diseases by targeting elusive biomarkers. Despite their utility, these aptamers are susceptible to easy degradation by multiple enzymes, presenting a significant challenge.

 

Professor Seung Soo Oh and his team from the Department of Materials Science and Engineering at Pohang University of Science and Technology (POSTECH), including Dr. Byunghwa Kang, and Dr. Soyeon V Park, have introduced a breakthrough approach using ionic liquids to address the challenges in functional nucleic acid research, paving the way for diverse applied research. Their findings have been published in Nucleic Acids Research.

 

Functional nucleic acids are termed as such for their versatility in not only storing and transmitting genetic information in living organisms but also in performing varied functions, such as detecting target molecules or catalyzing biochemical reactions similar to aptamers. However, these nucleic acids face obstacles in research applications due to vulnerability to degradation by hydrolases.3 Conventional preservation methods such as ultra-low-temperature cryogenic storage or chemical modification of nucleic acids fail to inhibit a wide array of enzymes, resulting in significant impairment of the nucleic acids’ useful functions.

 

The team shifted away from the conventional belief that “water is essential.” Although nucleic acids serve various roles and exhibit multiple functions in water, enzymes that break them down remain active in this medium. Hence, water acts as both the “home” and the “graveyard” for nucleic acids. The research team marked a significant milestone by globally validating the capability of nucleic acids to retain multiple functions in a choline dihydrogen phosphate-based ionic liquid. This ionic liquid, also present in our bodies, exhibits exceptional biocompatibility. The choline cation within the liquid effectively shields the negative charge of nucleic acids, preventing their contact with water and thereby fundamentally impeding hydrolysis.

 

In experiments, this liquid created an environment where nucleic acids resisted degradation regardless of the enzyme type, extending their half-life up to 6.5 million times. Even in extreme environments with a mix of seven different hydrolases, the nucleic acids remained completely intact and functional.

 

Furthermore, the team applied this innovation to enable aptamer-based biomolecular diagnostics within biological solutions for the first time. Previously, saliva containing numerous nucleic acid hydrolases made it impossible to use functional nucleic acids for biomarker detection. However, the team shielded the aptamers with an ionic liquid added to the saliva sample to achieve simple molecular diagnostics.

 

Professor Seung Soo Oh emphasized, “By demonstrating that nucleic acids can maintain functionality even in unexplored or contaminated samples and body fluids, we’ve demonstrated their limitless application potential.” Dr. Byunghwa Kang expressed hope, stating, “This research will significantly benefit the application of not only nucleic acids but also other molecules susceptible to hydrolysis.”

 

This research was conducted with support from various institutions, including grants from the National Research Foundation of Korea funded by the Ministry of Science and ICT, the Korea Evaluation Institute of Industrial Technology, the Institute of Civil Military Technology Cooperation funded by the Defense Acquisition Program Administration and the Ministry of Trade, Industry & Energy, the Korea Basic Science Institute, and the Brain Korea 21 FOUR project.



Journal

Nucleic Acids Research

DOI

10.1093/nar/gkad1093

Article Title

Ionic liquid-caged nucleic acids enable active folding-based molecular recognition with hydrolysis resistance

Article Publication Date

22-Nov-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

BBX Gene Family’s Role in Chrysanthemum Fungus Defense

October 21, 2025
Shifts in Colorectal Cancer Screening Methods Among Insured Populations

Shifts in Colorectal Cancer Screening Methods Among Insured Populations

October 21, 2025

Sex-Specific Liver Transcriptomes: Maternal Obesity’s Impact

October 21, 2025

Unraveling the T-cell Surge: Key Genes That Forecast T-cell Expansion in Cancer Immunotherapy

October 21, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1271 shares
    Share 508 Tweet 317
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    303 shares
    Share 121 Tweet 76
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    137 shares
    Share 55 Tweet 34
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    130 shares
    Share 52 Tweet 33

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Examining Autism Stigma on TikTok and Instagram

Scalable, Interpretable Model Explainer Enhances Multi-View Integration

Optimizing Machine Learning for Bioethanol from Sugarcane

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 66 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.